Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for outpatient painless gastroenteroscopy
ChiCTR2000038876Phase 4Recruiting
- Sponsor
- Yancheng First People's Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, butorphanol and propofol (3 arms), sponsored by Yancheng First People's Hospital. Primary endpoint: Anesthesia effect. Started Oct 2020; status: recruiting.
02
Drugs
remimazolambutorphanolpropofol
Beyond the preview
Go deeper on ChiCTR2000038876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038876.